• December 3, 2020
  • 0

(FILES) In this file photo Heather Lieberman (L), 28, receives a COVID-19 vaccination from Yaquelin De La Cruz at the Research Centers of America in Hollywood, Florida, on August 13, 2020. – A key facet of the global mad scramble by Pfizer, Moderna and other pharma groups to develop a viable coronavirus vaccine is the recruitment of tens of thousands of volunteers willing to participate in clinical trials. AFP’s correspondent in Miami, Leila Macor, took part in such a trial organized by US biotech firm Moderna, which on November 16, 2020 announced that its experimental vaccine against Covid-19 was nearly 95 percent effective.
Why did Macor, who suffers from asthma, decide to be one of Moderna’s 30,000 test subjects? Here, she recounts her experience, which began just weeks after her own father died of Covid-19 in Chile. (Photo by CHANDAN KHANNA / AFP) (Photo by CHANDAN KHANNA/AFP via Getty Images)

Upstate News Headlines

PHP Code Snippets Powered By : XYZScripts.com